← Back to your selection

T. Rowe Price Investment Management

Activity from announced rounds

Activity in this selectionomnimed-6908dc6e
Rounds participated in
5
Confirmed lead rounds
1
4 roles undisclosed
New companies
5
First participation on record · 0 follow-on
Funding in participating rounds
$2B
5 disclosed · full round size, not this investor’s share

By stage

Series C+3
Series B2

By primary sector

Biotech3
Climate tech1
Hardware1

By country

United States4
1

Rounds

5 in this selection
FORM ENERGY

Long-duration iron-air batteries designed to store electricity for multi-day grid needs.

$750MSeries G
Lead
Ollin Biosciences

Develops bispecific antibody therapies for retinal vascular diseases including diabetic macular edema and wet AMD

$330MSeries B
Role not disclosed
SiFive

Develops RISC-V processor IP for customizable and energy-efficient computing solutions

$400MSeries G
Role not disclosed
Cellares

Develops automated cell therapy manufacturing platforms

$257MSeries D
Role not disclosed
Mirador Therapeutics

Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases

$250MSeries B
Role not disclosed